Mineralys Therapeutics, Inc. (MLYS)
NASDAQ: MLYS · Real-Time Price · USD
38.02
+1.01 (2.73%)
At close: Nov 7, 2025, 4:00 PM EST
38.08
+0.06 (0.16%)
After-hours: Nov 7, 2025, 7:22 PM EST
Mineralys Therapeutics Market Cap
Mineralys Therapeutics has a market cap or net worth of $2.95 billion as of November 7, 2025. Its market cap has increased by 325.15% in one year.
Market Cap
2.95B
Enterprise Value
2.62B
1-Year Change
325.15%
Ranking
Category
Stock Price
$38.02
Market Cap Chart
Since the IPO on February 10, 2023, Mineralys Therapeutics's market cap has increased from $624.91M to $2.95B, an increase of 371.94%. That is a compound annual growth rate of 76.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 2.87B | 368.59% |
| Dec 31, 2024 | 612.65M | 73.31% |
| Dec 29, 2023 | 353.50M | -43.43% |
| Feb 10, 2023 | 624.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 839.37B |
| Johnson & Johnson | 450.47B |
| AbbVie | 387.13B |
| UnitedHealth Group | 291.28B |
| AstraZeneca | 260.82B |
| Novartis AG | 242.27B |
| Abbott Laboratories | 217.27B |
| Merck & Co. | 212.91B |